Research and Markets: Drugs of Abuse Testing Markets - Specific Segment of the In-Vitro Diagnostics (IVD) Market

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/63ea59/drugs_of_abuse_tes) has announced the addition of the "Drugs of Abuse Testing Markets" report to their offering.

This report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing. In the current medical diagnostics market, drugs of abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin. Moreover, special attention is paid to Substance Abuse and Mental Health Service Administration (SAMHSA) requirements, which aims to prevent substance abuse in the U.S. and so requires that certain corporations comply with anti-drug policies and testing.

This review covers the leading market players, the competitive landscape, and the promising pipeline products in the drugs of abuse testing markets. Specifically, areas examined in this study include: available and developing technologies in the field, the U.S. and global market size for drugs of abuse tests, and the profiles of companies that are focusing on the drugs of abuse testing market. Detailed charts with sales forecasts and market share data for the U.S. and global drugs of abuse testing markets are included.

Key Topics Covered:

To view the full extended table of contents, click the link below:

1. Overview

2. Introduction to Drugs of Abuse testing

3. Drugs of Abuse Testing Markets

4. Market Size and Analysis for Drugs of Abuse Testing

5. Specific Market Sectors for Drugs of Abuse Testing

6. Company Specific Instrumentation and Test Kit Review

7. In Vitro Diagnostic Technologies and Potential Applications

8. Business Analysis of Drugs of Abuse Testing Market

9. SWOT Analysis

10. Reimbursement Systems

11. Government Regulation

12. Company Profiles

Companies Mentioned:

• Abbott Laboratories
• AdnaGen
• Ambrilia Biopharma
• Radient Pharmaceuticals (Formerly AMDL)
• Beckman Coulter, Inc.
• Biomedical Diagnostics (Belgium)
• bioMrieux
• Bio-Rad Laboratories
• CanAg Diagnostics
• Dako
• DiaSorin
• Eiken Chemical
• Fujirebio
• Instrumentation Laboratory
• Johnson & Johnson
• Kyowa Medex
• Matritech
• Roche
• Siemens AG
• Sysmex
• Thermo Fisher Scientific
• Tosoh
• Trinity Biotech
• Wako
• Wallac

For more information visit http://www.researchandmarkets.com/research/63ea59/drugs_of_abuse_tes